中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/06 | 7,002 | 7,010 | 6,764 | 6,847 | -152 | -2.2% | 2,428,900 |
| 2024/12/30 | 7,117 | 7,121 | 6,975 | 6,999 | -106 | -1.5% | 1,680,800 |
| 2024/12/27 | 6,980 | 7,158 | 6,973 | 7,105 | +159 | +2.3% | 1,940,100 |
| 2024/12/26 | 6,923 | 6,973 | 6,910 | 6,946 | -28 | -0.4% | 1,174,200 |
| 2024/12/25 | 6,960 | 6,974 | 6,903 | 6,974 | +54 | +0.8% | 1,552,200 |
| 2024/12/24 | 6,897 | 6,978 | 6,885 | 6,920 | +38 | +0.6% | 901,900 |
| 2024/12/23 | 6,821 | 6,933 | 6,750 | 6,882 | +232 | +3.5% | 1,785,600 |
| 2024/12/20 | 6,802 | 6,825 | 6,650 | 6,650 | -52 | -0.8% | 2,700,400 |
| 2024/12/19 | 6,680 | 6,785 | 6,673 | 6,702 | -111 | -1.6% | 1,523,600 |
| 2024/12/18 | 6,976 | 6,976 | 6,796 | 6,813 | -188 | -2.7% | 2,357,600 |
| 2024/12/17 | 6,860 | 7,025 | 6,840 | 7,001 | +232 | +3.4% | 2,165,900 |
| 2024/12/16 | 6,610 | 6,769 | 6,572 | 6,769 | +175 | +2.7% | 1,618,300 |
| 2024/12/13 | 6,712 | 6,772 | 6,588 | 6,594 | -176 | -2.6% | 2,665,400 |
| 2024/12/12 | 6,784 | 6,834 | 6,745 | 6,770 | +33 | +0.5% | 1,872,600 |
| 2024/12/11 | 6,702 | 6,771 | 6,652 | 6,737 | ±0 | ±0% | 1,736,300 |
| 2024/12/10 | 6,850 | 6,854 | 6,692 | 6,737 | -68 | -1% | 2,092,800 |
| 2024/12/09 | 6,726 | 6,809 | 6,700 | 6,805 | +76 | +1.1% | 1,707,000 |
| 2024/12/06 | 6,800 | 6,875 | 6,708 | 6,729 | -36 | -0.5% | 1,398,200 |
| 2024/12/05 | 6,800 | 6,829 | 6,726 | 6,765 | -3 | ±0% | 1,254,400 |
| 2024/12/04 | 6,845 | 6,864 | 6,746 | 6,768 | -2 | ±0% | 1,461,900 |
| 2024/12/03 | 6,737 | 6,795 | 6,706 | 6,770 | +165 | +2.5% | 2,677,100 |
| 2024/12/02 | 6,574 | 6,654 | 6,490 | 6,605 | +7 | +0.1% | 1,490,000 |
| 2024/11/29 | 6,614 | 6,654 | 6,483 | 6,598 | -14 | -0.2% | 1,722,200 |
| 2024/11/28 | 6,594 | 6,715 | 6,570 | 6,612 | +36 | +0.5% | 1,845,700 |
| 2024/11/27 | 6,449 | 6,654 | 6,390 | 6,576 | +201 | +3.2% | 2,640,000 |
| 2024/11/26 | 6,397 | 6,429 | 6,315 | 6,375 | -122 | -1.9% | 1,713,800 |
| 2024/11/25 | 6,310 | 6,518 | 6,286 | 6,497 | +227 | +3.6% | 3,842,600 |
| 2024/11/22 | 6,348 | 6,389 | 6,270 | 6,270 | -113 | -1.8% | 2,466,200 |
| 2024/11/21 | 6,427 | 6,510 | 6,370 | 6,383 | -1 | ±0% | 1,627,200 |
| 2024/11/20 | 6,544 | 6,556 | 6,331 | 6,384 | -60 | -0.9% | 2,286,100 |
| 2024/11/19 | 6,491 | 6,499 | 6,345 | 6,444 | +17 | +0.3% | 3,211,200 |
| 2024/11/18 | 6,900 | 6,906 | 6,427 | 6,427 | -714 | -10% | 3,914,100 |
| 2024/11/15 | 7,268 | 7,349 | 7,141 | 7,141 | +11 | +0.2% | 1,687,800 |
| 2024/11/14 | 7,204 | 7,303 | 7,127 | 7,130 | +1 | ±0% | 1,395,500 |
| 2024/11/13 | 7,236 | 7,245 | 7,108 | 7,129 | -187 | -2.6% | 1,921,900 |
| 2024/11/12 | 7,426 | 7,476 | 7,273 | 7,316 | -109 | -1.5% | 1,886,300 |
| 2024/11/11 | 7,267 | 7,429 | 7,254 | 7,425 | +185 | +2.6% | 1,304,400 |
| 2024/11/08 | 7,252 | 7,290 | 7,176 | 7,240 | +194 | +2.8% | 2,377,200 |
| 2024/11/07 | 7,079 | 7,191 | 6,941 | 7,046 | -183 | -2.5% | 2,802,600 |
| 2024/11/06 | 7,085 | 7,229 | 6,945 | 7,229 | +144 | +2% | 2,611,000 |
| 2024/11/05 | 7,150 | 7,188 | 7,016 | 7,085 | -128 | -1.8% | 2,596,600 |
| 2024/11/01 | 7,190 | 7,310 | 7,155 | 7,213 | -127 | -1.7% | 1,936,500 |
| 2024/10/31 | 7,357 | 7,401 | 7,276 | 7,340 | ±0 | ±0% | 2,714,300 |
| 2024/10/30 | 7,510 | 7,568 | 7,340 | 7,340 | -378 | -4.9% | 4,797,400 |
| 2024/10/29 | 7,778 | 7,828 | 7,643 | 7,718 | -137 | -1.7% | 2,964,800 |
| 2024/10/28 | 7,280 | 7,869 | 7,275 | 7,855 | +986 | +14.4% | 6,574,000 |
| 2024/10/25 | 6,870 | 6,880 | 6,770 | 6,869 | -73 | -1.1% | 1,295,500 |
| 2024/10/24 | 6,912 | 7,053 | 6,828 | 6,942 | +52 | +0.8% | 1,993,300 |
| 2024/10/23 | 6,884 | 6,970 | 6,825 | 6,890 | +5 | +0.1% | 1,740,700 |
| 2024/10/22 | 7,000 | 7,035 | 6,873 | 6,885 | -118 | -1.7% | 1,554,000 |
101～
150
件表示中 / 3713件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 735,600円 | +1.7% | +5.0% | 3.40% | 29.53倍 | 6.37倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 359,200円 | +6.0% | +4.0% | 2.17% | 22.30倍 | 4.12倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 427,000円 | -1.1% | +75.3% | 4.68% | 29.25倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 689,600円 | +2.2% | +10.2% | 1.74% | 13.24倍 | 1.33倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,000円 | +0.9% | +380.2% | 5.61% | 19.14倍 | 1.64倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
